AVE 33.3% 0.2¢ avecho biotechnology limited

Ann: Chair's Address and CEO Presentation, page-6

  1. 8,604 Posts.
    lightbulb Created with Sketch. 83
    Human health


    • Multiple potential licensees undertaking due diligence•

    Multiple assets being considered •

    Minimal investment moving forward

    Excellent news.......we're gonna need a bigger bank
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.